Intravenous formalin for treatment of haemorrhage in horses

There is limited information in the literature regarding the clinical use of formalin for the treatment of haemorrhage in horses. This uncontrolled retrospective study summarises 11 cases that were treated with intravenous formalin at the Veterinary Health Center at Kansas State University from 2009 to 2019. The objective of this study was to describe signalment, clinical and laboratory findings, treatment and outcome of horses treated with intravenous formalin for potentially life-threatening haemorrhagic conditions. This study does not attempt to prove efficacy of intravenous formalin, but rather to report its clinical use and the associated details of those cases. Horses ranged in age from 2 to 23 years old. There were nine Quarter Horses, one Thoroughbred and one Appaloosa. Treated conditions included haemoabdomen (4/11), uterine haemorrhage (1/11), epistaxis (3/11), haemorrhage secondary to a mandibular laceration (2/11) and haemothorax (1/11). The most utilised dose was 0.476% formalin (50 mL 10% neutral buffered formalin diluted in 1 L of isotonic fluid). Some horses were also treated with aminocaproic acid, Yunnan Baiyao, whole blood transfusions and surgery. Ten out of the 11 horses survived to discharge with one horse reported by the owner to have died 2 weeks later of an unknown cause.     

Dogs mean arterial pressure and heart rate responses during high propofol plasma concentrations estimated by a pharmacokinetic model

Propofol total intravenous anesthesia should provide stability of the cardiovascular system. In this study, mean arterial pressure and heart rate were evaluated in eight healthy dogs anesthetized with increasing rates of propofol. The cerebral state index (CSI) was studied as an additional parameter. Although the estimated propofol plasma concentration reached a maximal value of 15.3 μg ml⁻¹, no hypotension or bradycardia were observed. Exploration of each animal’s data revealed high inter-individual variability regarding mean arterial pressure and heart rate. Considering the logarithmic of the concentration, a moderate depressant effect of propofol on mean arterial pressure was revealed in five dogs but the effect was not followed on heart rate.     

犬静脉泌尿系造影术研究

选本地健康成年犬20只(体重为10.5～25.0kg),在全麻状态下取腹背位评定,主要采用腹部压迫法摄取造影片。结果:(1)kVP=体厚(cm) 55,mAs=50(中速钨酸钙增感屏);(2)以跖外静脉及隐静脉为注射部位,60％复方泛影葡胺(0.50～0.75mL/kg在1min左右注完);(3)摄取肾实质、肾盂及全尿路的最佳时机分别为1、15及30min左右;(4)肾脏位于脊柱两侧T_(13)～L_4水平处。肾长径约为横径的2倍,约为L_2长度的3倍。肾盂属于肾内型,多呈漏斗状或三角形。肾盂的髓质边缘处有6～8对锯齿状肾盂盲囊。个别犬的输尿管有迂曲现象。     

Evaluation of an anaesthetic technique used in dogs undergoing craniectomy for tumour resection

ObjeCTIVE: To evaluate a total intravenous anaesthetic technique in dogs undergoing craniectomy. STUDY DESIGN: Prospective clinical study. ANIMALS: Ten dogs admitted for elective surgical resection of rostro-tentorial tumours. METHODS: All dogs were premedicated with methadone, 0.2 mg kg(-1) intramuscularly 30 minutes prior to induction of anaesthesia. Anaesthesia was induced with propofol administered intravenously (IV) to effect, following administration of lidocaine 1 mg kg(-1) IV and maintained with a continuous infusion of propofol at < or =0.4 mg kg(-1) minute(-1) during instrumentation and preparation and during movement of the animals to recovery. During surgery, anaesthesia was maintained using a continuous infusion of propofol at 相似文献   

Prolonged anesthesia using sevoflurane,remifentanil and dexmedetomidine in a horse

HistoryA 10–year old Arabian mare had a slow–growing mass on the lower right mandible and required a large partial mandibulectomy.Physical examinationNo abnormalities were detected apart from the mass.ManagementA temporary tracheostomy was performed pre–operatively. Anesthesia was induced with xylazine followed by ketamine and diazepam. For 13 hours, anesthesia was maintained using sevoflurane, dexmedetomidine and remifentanil infusions, with the exception of surgical preparation time. Intra–operatively, ventilation was delivered through the cuffed tracheotomy tube. Heart and respiratory rates, ECG, arterial pressures, inspired and expired gases, pulse oximetry values and body temperature were monitored. Dobutamine and whole blood were necessary, and romifidine was used to control recovery. Post–operatively, phenylbutazone and buprenorphine given systemically and bupivacaine administered through a wound soaker catheter were used to provide analgesia. Head–shaking from buprenorphine was controlled with acepromazine and detomidine once standing after 87 minutes in recovery. For 3 days after surgery, analgesia was provided with butorphanol, phenylbutazone and bupivacaine. The mare recovered well, appeared comfortable and started eating the following day with no signs of ileus.Follow–upSeven months later, the mare was doing well.ConclusionsSevoflurane, dexmedetomidine and remifentanil infusions were suitable for a long and invasive procedure.     

Pharmacokinetics and pulmonary distribution of gamithromycin after intravenous administration in foals

The long‐acting azalide antibiotic gamithromycin is marketed for intramuscular treatment of bovine and swine infections. Off‐label use in foals leads to severe local lesions likely caused by hyperosmolality of the injected solution. We provide evidence from a pharmacokinetic study in 10 warm‐blooded healthy foals for intravenous bolus injection of gamithromycin diluted in distilled water to be a safe and well tolerated alternative. By intravenous dosing, markedly higher plasma exposure and better penetration into bronchoalveolar lavage cells but lower distribution into epithelial lining fluid are achieved as after intramuscular or subcutaneous administration. Intravenously injected gamithromycin was tolerated without any adverse drug reactions. The protocols for treatment of equine pulmonary infections caused by Rhodococcus equi should be revised accordingly.     

A clinical evaluation of the pharmacokinetics and pharmacodynamics of intravenous alfaxalone in cyclodextrin in male and female rats following a loading dose and constant rate infusion

Objective

To characterise, as a clinical study, the pharmacokinetics and pharmacodynamics and describe the hypnotic effect of the neurosteroid alfaxalone (3α-hydroxy-5 α-pregnane-11, 20-dione) formulated with 2-hydroxypropyl-β-cyclodextrin in male and female rats.

外源褪黑素处理方式对荷斯坦奶牛体内褪黑素富集与代谢的影响

为研究正常情况下经产荷斯坦奶牛24 h内血液中褪黑素浓度的变化情况,探索不同外源褪黑素处理方式对荷斯坦奶牛血液褪黑素浓度的影响,本研究采用颈静脉注射、颈部皮下注射、颈部皮下埋植和口腔灌服外源褪黑素等方式处理经产荷斯坦奶牛,观察血液中褪黑素浓度的变化情况并分析褪黑素在体内的分泌规律及代谢速率。结果显示,在24 h内,经产荷斯坦奶牛血液中褪黑素浓度变化明显,04：00浓度最高,为8.30 ng/mL,16：00浓度最低,为2.08 ng/mL。皮下埋植和口腔灌服外源褪黑素以后,血液中褪黑素浓度升高幅度较小;皮下注射46.4、4.64和0.464 mg褪黑素后,血液中褪黑素浓度迅速升高,1 h后达到峰值,分别为561.94、487.03、92.89 ng/mL,极显著高于注射前（P<0.01）;静脉注射46.4、4.64和0.464 mg褪黑素后,血液中褪黑素浓度迅速升高,0.5 h之后达到峰值,分别为767.68、639.19、110.56 ng/mL,极显著高于注射前（P<0.01）,高水平褪黑素可稳定持续48 h。本研究证明了荷斯坦奶牛体内褪黑素分泌有明显的昼夜节律性,静脉或皮下注射外源褪黑素可以迅速提高血液中褪黑素的浓度,且血液中褪黑素的代谢速度与褪黑素的浓度高度相关,随着血液中褪黑素浓度的增加,褪黑素的代谢速度明显加快。     

Immunomodulation and immunodeficiency

This article briefly reviews the concepts of immunodeficiency and immunomodulation as they relate to selected skin diseases in the dog and cat. Immunodeficiency states are uncommon and may be associated with a subnormal or down-regulated immune system, including humoral deficiencies, such as IgA, and abnormal lymphocyte or neutrophil function. Establishing a causal relationship between a skin disease and presumed immunodeficient state has been difficult due to the rarity of such conditions, and the limited nature of the techniques used to characterise the immune system response. Severe combined immunodeficiency in dogs is a well characterised primary immunodeficiency state involving lymphocytes; retrovirus infection in cats may lead to an acquired immunodeficient state with some association with certain dermatological conditions although it remains unclear that infection is causally linked with disease. Immunomodulation usually implies stimulating the immune system along a beneficial pathway. Such a therapeutic approach may involve a wide variety of agents, for example intravenous immunoglobulin. There are few randomised controlled trials with veterinary patients that unequivocally demonstrate beneficial responses to immunomodulatory agents. Interferons are cytokines of major interest in human and veterinary medicine for their antiviral, anti-tumour and immunomodulatory effects. The advent of veterinary-licensed products containing recombinant interferon may enable demonstration of the efficacy of interferons for conditions such as canine papillomatosis and feline eosinophilic granuloma complex. Canine pyoderma has been treated with a number of presumed immunomodulatory agents with limited success. With more detailed knowledge of the pathogenesis of pyoderma it may be possible to develop efficacious immunomodulators.